Matches in SemOpenAlex for { <https://semopenalex.org/work/W201704258> ?p ?o ?g. }
- W201704258 endingPage "181" @default.
- W201704258 startingPage "163" @default.
- W201704258 abstract "Recent clinical data on selective estrogen receptor modulators (SERMs) have provided the basis for reassessment of the SERM concept. The molecular basis of SERM activity involves binding of the ligand SERM to the estrogen receptor (ER), causing conformational changes which facilitate interactions with coactivator or corepressor proteins, and subsequently initiate or suppress transcription of target genes. SERM activity is intrinsic to each ER ligand, which accomplishes its unique profile by specific interactions in the target cell, leading to tissue selective actions. We discuss the estrogenic and anti-estrogenic effects of early SERMs, such as clomiphene citrate, used for treatment of ovulation induction, and the triphenylethylene, tamoxifen, which has ER antagonist activity in the breast, and is used for prevention and treatment of ER-positive breast cancer. Since the development of tamoxifen, other triphenylethylene SERMs have been studied for breast cancer prevention, including droloxifene, idoxifene, toremifene, and ospemifene. Other SERMs have entered clinical development more recently, including benzothiophenes (raloxifene and arzoxifene), benzopyrans (ormeloxifene, levormeloxifene, and EM-800), lasofoxifene, pipendoxifene, bazedoxifene, HMR-3339, and fulvestrant, an anti-estrogen which is approved for breast cancer treatment. SERMs have effects on tissues containing ER, such as the breast, bone, uterine and genitourinary tissues, and brain, and on markers of cardiovascular risk. Current evidence indicates that each SERM has a unique array of clinical activities. Differences in the patterns of action of SERMs suggest that each clinical end point must be evaluated individually, and conclusions about any particular SERM can only be established through appropriate clinical trials." @default.
- W201704258 created "2016-06-24" @default.
- W201704258 creator A5011582505 @default.
- W201704258 creator A5030914107 @default.
- W201704258 creator A5042761913 @default.
- W201704258 creator A5053254718 @default.
- W201704258 creator A5073525642 @default.
- W201704258 date "2008-03-01" @default.
- W201704258 modified "2023-10-11" @default.
- W201704258 title "Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings" @default.
- W201704258 cites W1453600927 @default.
- W201704258 cites W1501286679 @default.
- W201704258 cites W1531964529 @default.
- W201704258 cites W1562190372 @default.
- W201704258 cites W1576412791 @default.
- W201704258 cites W1580928593 @default.
- W201704258 cites W1590666178 @default.
- W201704258 cites W1916689057 @default.
- W201704258 cites W1963570942 @default.
- W201704258 cites W1965740586 @default.
- W201704258 cites W1966756850 @default.
- W201704258 cites W1966792167 @default.
- W201704258 cites W1969511375 @default.
- W201704258 cites W1970028985 @default.
- W201704258 cites W1970416243 @default.
- W201704258 cites W1971022488 @default.
- W201704258 cites W1972694969 @default.
- W201704258 cites W1973374265 @default.
- W201704258 cites W1976472898 @default.
- W201704258 cites W1978757053 @default.
- W201704258 cites W1979801000 @default.
- W201704258 cites W1980617781 @default.
- W201704258 cites W1980871002 @default.
- W201704258 cites W1981476886 @default.
- W201704258 cites W1981874801 @default.
- W201704258 cites W1982676357 @default.
- W201704258 cites W1984670037 @default.
- W201704258 cites W1985031324 @default.
- W201704258 cites W1985160737 @default.
- W201704258 cites W1985216317 @default.
- W201704258 cites W1986364825 @default.
- W201704258 cites W1987775866 @default.
- W201704258 cites W1988005311 @default.
- W201704258 cites W1988055889 @default.
- W201704258 cites W1991567335 @default.
- W201704258 cites W1992221995 @default.
- W201704258 cites W1993268221 @default.
- W201704258 cites W1994453737 @default.
- W201704258 cites W1995071598 @default.
- W201704258 cites W1997883187 @default.
- W201704258 cites W2000023045 @default.
- W201704258 cites W2000077778 @default.
- W201704258 cites W2001507203 @default.
- W201704258 cites W2002232482 @default.
- W201704258 cites W2002255390 @default.
- W201704258 cites W2003019536 @default.
- W201704258 cites W2003219279 @default.
- W201704258 cites W2003726111 @default.
- W201704258 cites W2003863147 @default.
- W201704258 cites W2003996771 @default.
- W201704258 cites W2006669125 @default.
- W201704258 cites W2009429260 @default.
- W201704258 cites W2011246022 @default.
- W201704258 cites W2011448650 @default.
- W201704258 cites W2012804784 @default.
- W201704258 cites W2014324176 @default.
- W201704258 cites W2015930390 @default.
- W201704258 cites W2026287546 @default.
- W201704258 cites W2026579016 @default.
- W201704258 cites W2027836699 @default.
- W201704258 cites W2029608673 @default.
- W201704258 cites W2030617972 @default.
- W201704258 cites W2032958881 @default.
- W201704258 cites W2035195447 @default.
- W201704258 cites W2036222013 @default.
- W201704258 cites W2039576757 @default.
- W201704258 cites W2039629869 @default.
- W201704258 cites W2040109262 @default.
- W201704258 cites W2041938813 @default.
- W201704258 cites W2043347093 @default.
- W201704258 cites W2043909215 @default.
- W201704258 cites W2044211570 @default.
- W201704258 cites W2045389096 @default.
- W201704258 cites W2046770692 @default.
- W201704258 cites W2046776608 @default.
- W201704258 cites W2048257551 @default.
- W201704258 cites W2048813529 @default.
- W201704258 cites W2052711555 @default.
- W201704258 cites W2053194047 @default.
- W201704258 cites W2055792994 @default.
- W201704258 cites W2058771273 @default.
- W201704258 cites W2061948111 @default.
- W201704258 cites W2063167540 @default.
- W201704258 cites W2065022554 @default.
- W201704258 cites W2065689874 @default.
- W201704258 cites W2067905926 @default.
- W201704258 cites W2075345188 @default.
- W201704258 cites W2075870373 @default.